Wesper's Major Innovation in Sleep Diagnostics
At the forefront of advanced home sleep apnea testing, Wesper has made a significant announcement at the recent SLEEP 2026 event, held by the Associated Professional Sleep Societies. The company has introduced a groundbreaking multi-tier sleep diagnostic ecosystem designed to provide personalized sleep care solutions. This innovative platform boasts two distinct diagnostic pathways—Wesper Lab and Wesper Lite—integrating them onto a single unified system for enhanced patient management.
Two Distinct Diagnostic Pathways
The Wesper ecosystem separates its diagnostic offerings into two specialized tiers: Wesper Lab and Wesper Lite. Wesper Lab is a high-fidelity, respiratory-based testing solution that allows for an in-depth analysis of sleep patterns and potential apnea events. It employs a cannula-free system to monitor airflow, positional analysis, and detect central apnea events accurately. This level of testing is particularly beneficial for comprehensive follow-ups and tailored ongoing treatment strategies.
On the other hand, Wesper Lite serves a different purpose. This solution utilizes an optical sensor-based approach (PPG) for general diagnostics, designed primarily for high-volume screening and remote patient monitoring. These features are essential for clinics that experience a significant number of patients needing preliminary assessments without the complexities of invasive testing.
Flexible and Comprehensive Patient Management
With increasing demand for sleep testing services, Wesper's ecosystem stands out by giving healthcare providers the flexibility to cater to a diverse patient demographic. Providers can easily switch between the two tests without the need to re-onboard patients, fundamentally streamlining the diagnostic process and improving patient experience.
Dr. Amir Reuveny, the CEO and Founder of Wesper, emphasized the importance of personalized care, stating, "Sleep apnea is a complicated condition that presents uniquely in every patient, but existing sleep testing has often been approached as one-size-fits-all." The ability of physicians to accurately choose the right test for each patient based on their specific needs symbolizes a shift towards individualized healthcare.
Research Backing
Beyond the technology unveiling, Wesper is also presenting three noteworthy research studies at the SLEEP 2026. The studies focus on enhancing sleep apnea diagnostics through the lens of AI technology and provider-specific optimization. They underline the clinical validity and advantages behind the innovative ecosystem Wesper is establishing:
- - Provider-Tuned Autoscoring: This study showcases improvements in agreement rates between automated and provider-sourced Apnea-Hypopnea Index (AHI) scoring, indicating higher accuracy with personalized adjustments.
- - Positional OSA Phenotype: This research highlights the underrecognized positional obstructive sleep apnea (OSA) in obese patients, asserting the necessity of specialized diagnostic criteria.
- - AI-Driven Central Sleep Apnea Detection: A focus on how AI enhances the detection of central sleep apnea via auto-scoring in wearable HSAT setups.
About Wesper
Wesper aims to set a new standard in sleep diagnostics, providing an appropriate level of diagnostic power tailored to each patient's condition. The combination of high-fidelity data from Wesper Lab and the efficient screening capabilities of Wesper Lite presents a holistic approach to sleep healthcare. This unifying platform encompasses everything from initial diagnostics through to ongoing treatment and monitoring, all within a single patient record, ensuring seamless continuity of care.
As the landscape of sleep medicine continues to evolve, Wesper's commitment to innovation and individualized patient care reinforces its position as a leader in home sleep testing solutions. With the launch of this ecosystem at SLEEP 2026, Wesper underscores its mission to advance the effectiveness of sleep diagnostic practices worldwide.